why choose us

First received: August 11, 2024

Clinical Trial: Single-port Robotic Transanal Total Mesorectal Excision

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Rectal Cancer Patients

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety Assessment of Single-port Robotic Transanal Total Mesorectal Excision for Mid and Low Rectal Cancer: a Phase 2a Trial Based on the IDEAL Framework

Brief Summary: This is a phase 2a clinical trial based on the IDEAL framework to evaluate the safety, feasibility and clinical efficacy of single-port robotic transanal total mesorectal excision (SPr-taTME )surgery.For safety, intraoperative adverse events and 30-day morbidity.For efficacy, successful completion of predefined procedural steps without conversion.The transanal surgical platform consists of a single-port robotic system, while the transabdominal approach can be performed laparoscopically or with single-port robotic…

Read more